pentetate calcium trisodium
PENTETATE CALCIUM TRISODIUM (pentetate calcium trisodium) is ca-dtpa forms stable chelates with metal ions by exchanging calcium for a metal of greater binding capacity. Approved for individuals with known, suspected internal contamination with plutonium, americium and 1 more indications. First approved in 2004.
Drug data last refreshed 12h ago · AI intelligence enriched 2mo ago
Pentetate Calcium Trisodium (Ca-DTPA) is a chelating agent administered intravenously or by inhalation to treat internal radioactive contamination with plutonium, americium, and curium. It works by forming stable chelate complexes with these radioactive metals, which are then rapidly excreted via glomerular filtration into urine, thereby increasing elimination rates and reducing tissue burden.
As an niche radiological emergency countermeasure with LOE approaching, the brand team is likely small and focused on government contracts and emergency preparedness channels rather than traditional commercial growth.
Ca-DTPA forms stable chelates with metal ions by exchanging calcium for a metal of greater binding capacity. The radioactive chelates are then excreted by glomerular filtration into the urine. In animal studies, Ca-DTPA forms less stable chelates with uranium and neptunium in vivo resulting in the…
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on Pentetate Calcium Trisodium offers a specialized career path focused on radiological emergency preparedness, government contracting, and regulatory compliance rather than traditional pharmaceutical commercial development. This role is best suited for professionals interested in public health infrastructure, biosecurity, and niche therapeutic areas with stable but limited market opportunity.